N511 Module 7 assignment: Shadow Health reflection essay on COPD maintenance therapy, a full sample

Two Bronchodilators in One Device She Can Actually Use: Reflecting on COPD Maintenance Therapy for a 67-Year-Old With Arthritic Hands

Student Name

Master of Science in Nursing Program, Aspen University

N511: Advanced Pharmacology

Instructor Name

Month Day, Year

Two Bronchodilators in One Device She Can Actually Use: Reflecting on COPD Maintenance Therapy for a 67-Year-Old With Arthritic Hands

The digital patient in this module's ShadowHealth COPD exam, a composite for this essay, is a 67-year-old retired seamstress with COPD who uses only an albuterol inhaler, now four to five times a day. She has a modified Medical Research Council dyspnea grade of 2, a COPD Assessment Test score of 18, and one exacerbation treated at home with prednisone last winter. Her blood eosinophil count is 150 cells/µL, and she has rheumatoid arthritis affecting her hands. This essay reflects on my exam and answers the module's prompts.

Reflection and Selection Rationale

I took a thorough respiratory history but did not ask her to show me how she uses her inhaler until the exam prompted it. When she did, she exhaled into the mouthpiece and did not hold her breath. Poor technique is common: a systematic review found that only about a third of patients used their inhalers correctly (Sanchis et al., 2016).

Her symptoms are high and she has had one moderate exacerbation without hospitalization, which places her in GOLD group B. The 2023 GOLD report recommends a combination of a long-acting muscarinic antagonist and a long-acting beta-2 agonist for this group, and reserves an inhaled corticosteroid for patients with frequent exacerbations and blood eosinophils of 300 cells/µL or more (Agustí et al., 2023). With an eosinophil count of 150, she would not benefit enough from a corticosteroid to justify its pneumonia risk. I would prescribe tiotropium/olodaterol by soft mist inhaler, two puffs once daily, and keep albuterol for rescue. The soft mist device releases a slow aerosol that does not require a forceful inhalation, and it can be fitted with a loading aid for weak hands. The best drug fails in a device the patient cannot operate.

Monitoring, Adverse Effects, and Education

I would reassess her in four to six weeks: rescue inhaler use, CAT score, and inhaler technique observed directly. Tiotropium's anticholinergic action commonly dries the mouth and, less often, can precipitate urinary retention or aggravate narrow-angle glaucoma; olodaterol can cause tremor and palpitations. She should avoid adding other anticholinergic drugs, such as over-the-counter sleep aids containing diphenhydramine.

Teaching would cover once-daily timing, a demonstration with teach-back, rinsing and cleaning the device, and a written action plan for flares. Nonpharmacologic measures matter as much: pulmonary rehabilitation, influenza and pneumococcal vaccination, and staying tobacco-free (Agustí et al., 2023). Respiratory syncytial virus is now preventable as well: the 2023 federal recommendation allowed adults aged 60 and older to receive a single vaccine dose through shared clinical decision-making, with chronic lung disease named among the conditions that raise the risk of severe illness (Melgar et al., 2023). For her, that conversation belongs at the same visit.

Looking Ahead

From now on I will watch the patient use the inhaler before changing the drug in it. Her rising albuterol use reflected both undertreatment and poor technique, and only one of those problems could be solved with a prescription.

References

Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., Mortimer, K., Papi, A., Pavord, I., Roche, N., Salvi, S., Sin, D. D., Singh, D., Stockley, R., López Varela, M. V., ... Vogelmeier, C. F. (2023). Global Initiative for Chronic Obstructive Lung Disease 2023 report: GOLD executive summary. European Respiratory Journal, 61(4), Article 2300239. https://doi.org/10.1183/13993003.00239-2023

Melgar, M., Britton, A., Roper, L. E., Talbot, H. K., Long, S. S., Kotton, C. N., & Havers, F. P. (2023). Use of respiratory syncytial virus vaccines in older adults: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023. MMWR. Morbidity and Mortality Weekly Report, 72(29), 793-801. https://doi.org/10.15585/mmwr.mm7229a4

Sanchis, J., Gich, I., & Pedersen, S. (2016). Systematic review of errors in inhaler use: Has patient technique improved over time? Chest, 150(2), 394-406. https://doi.org/10.1016/j.chest.2016.03.041